Healthcare AI Acquisition Corp., a blank check company focused on effecting a merger or similar business combination, has released its Form 10-Q report. The report provides an overview of the company's recent business activities and operational strategy, particularly following its Initial Public Offering (IPO) and subsequent sponsor handover.
Business Highlights
Company Overview
Healthcare AI Acquisition Corp is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. As of the report date, no business combination target has been selected.
Initial Public Offering
The company completed its Initial Public Offering on December 14, 2021, raising gross proceeds of $200 million through the sale of 20 million units at $10 per unit. An additional $15.6 million was raised through the sale of over-allotment units.
Trust Account Management
Following the IPO, $219.9 million was placed in a trust account, invested in U.S. government securities or money market funds. The funds are intended for use in a future business combination.
Sponsor Handover
On June 12, 2023, a significant change in sponsorship occurred with the transfer of founder shares to Atticus Ale, LLC, the new sponsor. This included amendments to allow conversion of Class B shares to Class A shares and extensions for business combination deadlines.
Share Redemptions
Following the sponsor handover, a large number of shares were redeemed by public shareholders, resulting in significant withdrawals from the trust account.
Management Changes
The company underwent a management transition with a new team led by Mr. Zikang Wu following the sponsor handover.
Business Combination Deadline
The company has until December 14, 2024, to complete a business combination. If not completed by this date, the company will undergo mandatory liquidation and dissolution.
Operational Strategy
The company intends to use proceeds from its IPO and private placement warrants to consummate an initial business combination. The management has broad discretion over the application of these funds.
Future Outlook
The company faces uncertainty regarding its ability to consummate a business combination by the termination date. There is substantial doubt about its ability to continue as a going concern if a business combination is not completed.
SEC Filing: